Astrazeneca plc Overview
Astrazeneca plc (AZN) has a PEG ratio of 43.37, above the Healthcare sector average of 1.26.
Get informed when a big investor buys or sells
+ Follow43.37
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
The latest PEG ratio for AZN is 43.37. That is above the Healthcare sector average of 1.26. Investors often review this figure alongside Astrazeneca plc's historical trend and sector peers before judging valuation or financial health.
Against Healthcare companies, AZN currently prints 43.37 for PEG ratio, while the sector average sits near 1.26. That is roughly 3349.3% above the sector mean. Large gaps often invite a closer look at Astrazeneca plc's growth, margins, and balance sheet.
A PEG ratio of 43.37 for Astrazeneca plc is not 'good' or 'bad' on its own. Compare it with the peer average (1.26) and with AZN's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.
After noting AZN's PEG ratio (43.37), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack Astrazeneca plc's PEG ratio against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.
